TScan Therapeutics Announces Upcoming Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Announces Upcoming Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition

By

TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting

By

TScan Therapeutics to Participate in Upcoming Investor Conferences

By

TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures

By

TScan Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

By

TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

By

TScan Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference

By

TScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology

By

TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer

By

TScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium

By